Beam Therapeutics Inc. (NASDAQ: BEAM): Precision genetic medicine innovator, strong buy
Beam Therapeutics Inc. (NASDAQ: BEAM) is a pioneering biotechnology company headquartered in Cambridge, MA, at the forefront of precision genetic medicine. Founded in 2017 by esteemed scientists David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung, Beam is dedicated to revolutionizing the treatment of genetic diseases through its innovative platform.